Research Topics
Genomes and Genes
| Ching Hon PuiSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching Hon Pui
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 30:2005-12. 2012..Treatment outcome for black patients with cancer has been significantly worse than for their white counterparts. We determined whether recent improved treatment had narrowed the gap in outcome between black and white pediatric patients...
Results of therapy for acute lymphoblastic leukemia in black and white childrenChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
JAMA 290:2001-7. 2003..Treatment results for acute lymphoblastic leukemia (ALL) clearly have improved over the past decade, but black children have not fared as well as white children in large national trials...
ClofarabineChing-Hon Pui
Leukemia/Lymphoma Division, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, Tennessee 38105-2794, USA
Nat Rev Drug Discov 4:369-70. 2005
ClofarabineChing Hon Pui
Leukemia Lymphoma Division, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Nat Rev Drug Discov . 2005..It is the first new drug for paediatric leukaemia to be approved in more than a decade, and the only one to receive approval for paediatric use before adult use...
Neonatal leukemia: a nemesis for pediatric oncologists?Ching Hon Pui
St Jude Children s Research Hospital and the University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 47:234-5. 2006
Treatment of acute lymphoblastic leukemiaChing-Hon Pui
Department of Hematology and Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
N Engl J Med 354:166-78. 2006
Is mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?Ching Hon Pui
Departments of Oncology and Pharmaceutical Sciences, St Jude Children s Research Hospital, and Colleges of Medicine and Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA
Leuk Lymphoma 47:2431-2. 2006
Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemiaChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
N Engl J Med 349:640-9. 2003..We determined the long-term survival and the rates of health insurance coverage, marriage, and employment among patients who had attained at least 10 years of event-free survival...
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemiaChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Clin Oncol 23:7936-41. 2005..Our goal was to use the information to further refine therapy and advance cure rates...
Childhood acute lymphoblastic leukaemia--current status and future perspectivesC H Pui
Leukaemia Lymphoma Division, Fahad Nassar Al Rashid Chair of Leukaemia Research at St Jude Children s Research Hospital, Memphis, TN 38105, USA
Lancet Oncol 2:597-607. 2001..Ultimately, treatment based on biological features of leukaemic cells, host genetics, and the amount of residual disease should improve cure rates further...
Rasburicase: a potent uricolytic agentChing Hon Pui
St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, Tennessee 38105, USA
Expert Opin Pharmacother 3:433-42. 2002..Rasburicase is a safe and effective agent in the prevention or treatment of hyperuricaemia in cancer patients...
Can the genotoxicity of chemotherapy be predicted?Ching Hon Pui
St Jude Children s Research Hospital, Memphis, TN 38105, USA
Lancet 364:917-8. 2004
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal regionChing Hon Pui
St Jude Children s Research Hospital and the University of Tennessee, College of Medicine, Memphis, TN 38105, USA
Lancet 359:1909-15. 2002....
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 104:2690-6. 2004..01% or more at the end of the 6-week remission induction phase. Our results suggest the efficacy of early intensification of intrathecal chemotherapy and provide the basis for studies omitting cranial irradiation altogether...
Childhood acute lymphoblastic leukemiaChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, and Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
Rev Clin Exp Hematol 6:161-80; discussion 200-2. 2002..In the interim, prospective clinical trials have provided valuable clues that are further increasing the cure rate of childhood acute lymphoblastic leukemia...
Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia WorkshopC-H Pui
St Jude Children's Research Hospital, Memphis, TN, USA
Leukemia 18:1043-53. 2004
Acute lymphoblastic leukemiaChing-Hon Pui
Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA
N Engl J Med 350:1535-48. 2004
International collaboration on childhood leukemiaChing Hon Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Int J Hematol 78:383-9. 2003..quot;Twinning" partnerships between a well-established individual institution or study group and a pediatric cancer unit in a developing country has proved to be the most successful strategy to date...
Toward optimal use of intrathecal liposomal cytarabineChing-Hon Pui
Department of Oncology, St. Jude Children's Research Hospital, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
Leuk Lymphoma 48:1672-3. 2007
Current management and challenges of malignant disease in the CNS in paediatric leukaemiaChing Hon Pui
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38015 2794, USA
Lancet Oncol 9:257-68. 2008..Perhaps the most formidable challenge is to treat children with CNS relapse after a short initial remission or cranial irradiation...
Recent research advances in childhood acute lymphoblastic leukemiaChing Hon Pui
St Jude Children s Research Hospital and University of Tennessee Health Science Center, Memphis, Tennessee 38105 2794, USA
J Formos Med Assoc 109:777-87. 2010..The ultimate challenge is to gain a clear understanding of the factors that give rise to childhood leukemia in the first place, and enable preventive strategies to be devised and implemented...
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing Hon Pui
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 29:386-91. 2011..We reviewed the outcome of older adolescents (age 15 to 18 years) treated in four consecutive Total Therapy studies to determine if recent improved treatment extended to this high-risk group...
Treating childhood acute lymphoblastic leukemia without cranial irradiationChing Hon Pui
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
N Engl J Med 360:2730-41. 2009..Prophylactic cranial irradiation has been a standard treatment in children with acute lymphoblastic leukemia (ALL) who are at high risk for central nervous system (CNS) relapse...
T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcomeChing Hon Pui
Department of Oncology, St Jude Children s Research Hospital and the University of Tennessee Health Science Center, Memphis, TN 38105, USA
Cancer Cell 15:85-7. 2009....
Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphomaC H Pui
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 19:697-704. 2001....
Biology, risk stratification, and therapy of pediatric acute leukemias: an updateChing Hon Pui
St Jude Children s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA
J Clin Oncol 29:551-65. 2011....
Genetic studies in acute lymphoblastic leukemiaC H Pui
Departments of Hematology Oncology and Pathology, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105, USA
Acta Paediatr Taiwan 41:303-7. 2000....
Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemiaC H Pui
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 16:3768-73. 1998..To reassess the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia (ALL)...
Challenging issues in pediatric oncologyChing Hon Pui
St Jude Children s Research Hospital and the University of Tennessee Health Science Center, 262 Danny Thomas Place, Memphis, TN 38105, USA
Nat Rev Clin Oncol 8:540-9. 2011..Finally, palliative care should be included as an essential part of cancer management to prevent and relieve the suffering and to improve the quality of life of patients and their families...
Central nervous system disease in hematologic malignancies: historical perspective and practical applicationsChing Hon Pui
St Jude s Children s Research Hospital, Memphis, TN 38105, USA
Semin Oncol 36:S2-S16. 2009..In this article, we review current and past practice of intrathecal therapy in ALL and NHL and the risk models that aim to identify predictors of CNS relapse in NHL...
New therapeutic strategies for the treatment of acute lymphoblastic leukaemiaChing Hon Pui
Department of Oncology, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, Tennessee 38105, USA
Nat Rev Drug Discov 6:149-65. 2007....
Acute lymphoblastic leukaemiaChing Hon Pui
Department of Oncology, St Jude Children s Research Hospital and University of Tennessee Health Science Center, Memphis, TN 38105, USA
Lancet 371:1030-43. 2008....
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Leukemia 24:371-82. 2010..The next main challenge is to further increase cure rates while improving quality of life for all patients...
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemiaGaston K Rivera
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Cancer 103:368-76. 2005..The authors studied the clinical outcome of 106 children with acute lymphoblastic leukemia (ALL) who developed a bone marrow recurrence as the first adverse event after contemporary intensified therapy...
Treatment outcome in older patients with childhood acute myeloid leukemiaJeffrey E Rubnitz
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 118:6253-9. 2012..To the authors' knowledge, the impact of age relative to that of other prognostic factors on the outcome of patients treated in recent trials is unknown...
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemiaNobuko Hijiya
Department of Oncology, St Jude Children s Research Hospital, 332 North Lauderdale St, Memphis, TN 38105 2794, USA
Blood 108:3997-4002. 2006..Further, the systemic clearance of methotrexate, teniposide, etoposide, and cytarabine did not differ with BMI (P > .3). We conclude that BMI does not affect the outcome or toxicity of chemotherapy in this patient population with ALL...
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemiaJun J Yang
St Jude Children s Research Hospital, Memphis, TN 38105, USA
JAMA 301:393-403. 2009..Pediatric acute lymphoblastic leukemia (ALL) is the prototype for a drug-responsive malignancy. Although cure rates exceed 80%, considerable unexplained interindividual variability exists in treatment response...
Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantationHiroto Inaba
Department of Bone Marrow Transplantation and Cellular Therapy, MS 1130, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 3678, USA
J Clin Oncol 30:3991-7. 2012..To measure longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation (HSCT)...
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz
Department of Oncology, St Jude Children s Research Hospital and the University of Tennessee Health Science Center, Memphis, TN 38105 2794, USA
Lancet Oncol 11:543-52. 2010....
Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effectsLisa R Treviño
St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Clin Oncol 27:5972-8. 2009..Our aim was to identify the genetic basis of interindividual variability in methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia (ALL)...
Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemiaDeborah French
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 113:4512-20. 2009..We conclude that acquired genetic variation in leukemia cells has a stronger influence on MTXPG accumulation than inherited genetic variation...
Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2Christian Flotho
Department of Pathology, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105, USA
Blood 108:1050-7. 2006..Therefore, this gene is a strong candidate for inclusion in gene expression arrays specifically designed for leukemia diagnosis...
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesisGianluigi Zaza
St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA
Blood 104:1435-41. 2004..These findings have established that TEL-AML1 ALL has significantly lower de novo purine synthesis and differential expression of genes involved in purine metabolism...
Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemiaJun J Yang
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Blood 120:4197-204. 2012..All trials are registered at www.clinicaltrials.gov or www.cancer.gov (COG P9904: NCT00005585; COG P9905: NCT00005596; COG P9906: NCT00005603; St Jude Total XIIIB: NCI-T93-0101D; and St Jude Total XV: NCT00137111)...
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba
Department of Oncology, MS 260, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 3678, USA
J Clin Oncol 30:3625-32. 2012..Response can now be assessed by minimal residual disease (MRD) monitoring with flow cytometry or polymerase chain reaction (PCR). We determined the relation among the results of these approaches and their prognostic value...
Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphomaEvguenia J Karimova
Department of Radiological Sciences, Division of Diagnostic Imaging and Biostatistics, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Clin Oncol 25:1525-31. 2007..We determined clinical and imaging risk factors predicting clinical joint outcomes of femoral head osteonecrosis in pediatric patients with leukemia or lymphoma...
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemiaShinji Kishi
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, University of Tennessee, Memphis, TN 38105, USA
Blood 103:67-72. 2004..Prednisone strongly induces etoposide clearance, genetic polymorphisms may predict the constitutive and induced clearance of etoposide, and the relationship between genotype and phenotype differs by race...
Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experienceJeffrey E Rubnitz
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 48:10-5. 2007..The association between race and outcome of treatment for childhood acute myeloid leukemia (AML) has not been adequately studied...
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemiaJitesh D Kawedia
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 119:1658-64. 2012..019). In conclusion, systemic clearance of dexamethasone is higher in patients with anti-asparaginase antibodies. Lower exposure to both drugs was associated with an increased risk of relapse...
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWing Leung
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 118:223-30. 2011..10; P = .01) at the time of transplantation. We concluded that transplantation has improved over time and should be considered for all children with very high-risk leukemia, regardless of matched donor availability...
A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemiaChristian Flotho
Departments of Pathology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Blood 110:1271-7. 2007..Incorporation of the expression levels of these genes into existing strategies of risk classification could improve clinical management...
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate dispositionLaura B Ramsey
Pharmaceutical Sciences Department, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Genome Res 22:1-8. 2012..8% of SLCO1B1's effects (1.9% of total variation) and had larger effect sizes than common NS variants. Our results show that rare variants are likely to have an important effect on pharmacogenetic phenotypes...
ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemiaHeng Xu
St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
J Clin Oncol 30:751-7. 2012..We sought to determine the contribution of ARID5B single nucleotide polymorphisms (SNPs) to racial disparities in ALL susceptibility and treatment outcome...
Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemiaJohn T Sandlund
Department of Hematology Oncology, St Jude Children s Research Hospital, and the University of Tennessee, College of Medicine, Memphis, TN 38105, USA
Blood 100:43-7. 2002....
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cancer 116:98-105. 2010..The prognosis after recurrence of pediatric acute myeloid leukemia (AML) is poor, and effective salvage regimens are urgently needed...
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaElaine Coustan-Smith
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Lancet Oncol 10:147-56. 2009..We studied leukaemic cells, collected at diagnosis, to identify cases with ETP features and determine their clinical outcome...
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaJitesh D Kawedia
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 2794, USA
Blood 117:2340-7; quiz 2556. 2011..Overall, older age, lower albumin, higher lipid levels, and dexamethasone exposure were associated with osteonecrosis and may be linked by inherited genomic variation...
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemiaMary V Relling
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, 332 N Lauderdale, Memphis, TN 38105 2794, USA
J Clin Oncol 22:3930-6. 2004..Putative risk factors for osteonecrosis have included being female, white race, and older age. Our goal was to define possible genetic risk factors for osteonecrosis among children treated for newly diagnosed ALL...
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemiaKristine R Crews
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 20:4217-24. 2002....
Global gene expression as a function of germline genetic variationDeborah French
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Hum Mol Genet 14:1621-9. 2005....
Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemiaNobuko Hijiya
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
JAMA 297:1207-15. 2007..Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia...
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang
St Jude Children s Research Hospital, Memphis, TN, USA
Blood 112:4178-83. 2008....
Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemiaJessica R Roberson
Department of Hematology Oncology, St Jude Children s Research Hospital, and the University of Tennessee College of Medicine, Memphis, Tennessee, USA
Pediatr Blood Cancer 50:542-8. 2008..The percentage of myeloperoxidase (MPO)-positive blast cells is associated with prognosis in adult acute myeloid leukemia (AML), but this association is unsubstantiated in pediatric AML...
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemiaHiroto Inaba
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 29:3293-300. 2011..To assess the toxicity, pharmacokinetics, and pharmacodynamics of multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in children with relapsed/refractory leukemia...
Effect of race on the outcome of pediatric patients with Hodgkin's lymphomaMonika L Metzger
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Clin Oncol 26:1282-8. 2008..We examine the effects of race on clinical outcomes among children with Hodgkin's lymphoma (HL) treated with contemporary therapy at a tertiary care children's hospital...
Prognostic factors and outcome of recurrence in childhood acute myeloid leukemiaJeffrey E Rubnitz
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 109:157-63. 2007..Outcome after recurrence of childhood acute myeloid leukemia (AML) is poor. We performed this study to identify prognostic factors for recurrence and for survival after recurrence of AML...
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatmentMary V Relling
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Blood 101:3862-7. 2003..Even when children receiving irradiation were excluded, the incidence was still higher in those receiving G-CSF (P =.019). In the setting of intensive antileukemic therapy, short-term use of G-CSF may increase the risk of t-ML...
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trialTorben S Mikkelsen
St Jude Children s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA
J Clin Oncol 29:1771-8. 2011....
Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemiaScott C Howard
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
JAMA 288:2001-7. 2002..Traumatic or bloody lumbar puncture (LP) reduces the diagnostic value of the procedure and may worsen the outcome of patients with acute lymphoblastic leukemia (ALL). Little is known about the risk factors for traumatic and bloody LP...
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignanciesJavier G Blanco
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis TN 38105, USA
Pharmacogenetics 12:605-11. 2002..403), 6.5% vs. 12.5% in blacks (P = 0.508), and 69.6% vs. 75.0% in Hispanics (P= 0.663). Our data do not support an association between common CYP3A4, NQO1 or CYP3A5 polymorphisms and the risk of t-ML in children treated for ALL...
Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in childrenRobert P Sanders
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
Br J Haematol 130:781-7. 2005..Febrile and allergic transfusion reactions were rare in paediatric patients transfused with leucoreduced, irradiated blood products, whether premedication was used or not...
Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemiaLandry K Kamdem
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Pharmacogenet Genomics 18:507-14. 2008..One of the adverse effects of glucocorticoids is hypertension. Our aim was to define the frequency of and clinical and genetic risk factors for steroid-induced hypertension...
Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemiaSima Jeha
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA
Blood 108:3302-4. 2006..9% versus 78% +/- 3.1% (P = .08). These data suggest that CD20 expression is not associated with inferior outcome in pediatric patients treated with contemporary regimens...
NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemiaJeffrey E Rubnitz
Department of Oncology, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 2794, USA
J Clin Oncol 28:955-9. 2010..We propose to further investigate the efficacy of KIR-mismatched NK cells in a phase II trial as consolidation therapy to decrease relapse without increasing mortality in children with AML...
Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaR C Ribeiro
Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N, Lauderdale, Memphis, TN 38105-2794, USA
Leukemia 15:891-7. 2001..Therefore, the clinical usefulness of MR imaging as a screening tool for AVNB in this set of patients remains uncertain...
Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapyR Y McNall
Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA
J Pediatr Hematol Oncol 23:309-11. 2001..Intravenous immunoglobulin was administered and the patient's aplastic anemia resolved completely within 3 weeks. This highlights the importance of alertness to the possibility of parvovirus infection in children with cancer...
Germline genomic variants associated with childhood acute lymphoblastic leukemiaLisa R Treviño
St Jude Children s Research Hospital, Memphis, Tennessee, USA
Nat Genet 41:1001-5. 2009..86, respectively) and were associated with methotrexate accumulation and gene expression pattern in leukemic lymphoblasts. We conclude that germline variants affect susceptibility to, and characteristics of, specific ALL subtypes...
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1S Jeha
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Leukemia 23:1406-9. 2009..These data suggest that with contemporary treatment, patients with the t(1;19) and TCF3/PBX1 fusion have a favorable overall outcome but increased risk of CNS relapse...
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
Leukemia 15:1326-30. 2001..They also suggest that dose intensification of etoposide and addition of 2-CDA may also offer an advantage. This study underscores the dependence of the prognostic impact of cytogenetic features on the efficacy of treatment...
Clinical implications and surgical management of intussusception in pediatric patients with Burkitt lymphomaHimesh Gupta
Department of Surgery, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Pediatr Surg 42:998-1001; discussion 1001. 2007..We determined the incidence, presentation, stage, and outcome of children with Burkitt lymphoma presenting with intussusception...
Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndromeW Leung
The Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA
Bone Marrow Transplant 27:717-22. 2001..Immune function 1 year after transplantation and the incidences and spectra of late sequelae were similar for both groups during a median of 3.5 years (range, 1.5 to 7.2 years) of follow-up...
Ancestry and pharmacogenetics of antileukemic drug toxicityShinji Kishi
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 109:4151-7. 2007..026). The genotype-phenotype associations were similar whether analyses were adjusted by self-reported race or ancestry-informative genetic markers. Germ-line polymorphisms are significant determinants of toxicity of antileukemic therapy...
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileMichael J Sorich
Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, Tennessee, United States of America
PLoS Med 5:e83. 2008..Therefore, we measured the in vivo antileukemic effects of MTX and identified genes whose expression differed significantly in patients with a good versus poor response to MTX...
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemiaCharles G Mullighan
Department of Pathology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
N Engl J Med 360:470-80. 2009..Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined...
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseNobuko Hijiya
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
Cancer 112:1983-91. 2008..The authors evaluated the response rate, toxicity, and pharmacokinetics of topotecan given before standard induction therapy for childhood acute lymphoblastic leukemia (ALL) in first relapse...
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA
Blood 97:3727-32. 2001..Allogeneic transplantation during remission offers the best chance of cure; in the absence of remission, transplantation offers no advantage over chemotherapy alone. (Blood. 2001;97:3727-3732)..
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intoleranceC R Yates
St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Ann Intern Med 126:608-14. 1997....
Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemiaKristine R Crews
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105 3678, USA
Cancer 116:227-32. 2010....
Childhood cancer epidemiology in low-income countriesScott C Howard
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 112:461-72. 2008..POND4kids.org), which allows collection, analysis, and sharing of data...
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research HospitalJeffrey E Rubnitz
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Blood 113:5083-9. 2009..We also suggest that hematopoietic stem cell transplantation is often not required for cure of these patients...
Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group studyJeffrey E Rubnitz
Department of Oncology, Mail Stop 260, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105 2794, USA
J Clin Oncol 26:2186-91. 2008..To prospectively determine the prognostic significance of the TEL-AML1 fusion in children with acute lymphoblastic leukemia (ALL)...
High-risk childhood acute lymphoblastic leukemiaDeepa Bhojwani
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Clin Lymphoma Myeloma 9:S222-30. 2009..Genome-wide interrogation of leukemic cell genetic abnormalities and germline genetic variations promise to identify new molecular targets for therapy...
Validity and reliability of a new instrument to measure cancer-related fatigue in adolescentsPamela S Hinds
Division of Nursing Research, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
J Pain Symptom Manage 34:607-18. 2007..Findings further indicate that the FS-A can be used to measure change over time (t=2.55, P<0.01). In summary, the FS-A has moderate to strong reliability and impressive validity coefficients for a new research instrument...
A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasiaJohn T Sandlund
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA
Cancer Genet Cytogenet 168:69-72. 2006..1) that rearranged BCL6 and placed it adjacent to MYC. We speculate that this genetic lesion occurred as a result of chromosomal instability due to the underlying disease...
Obesity in survivors of childhood acute lymphoblastic leukemia and lymphomaBassem I Razzouk
Department of Hematology Oncology, St Jude Children s Research Hospital and the University of Tennessee Health Science Center, Memphis, TN 38105 2794, USA
J Clin Oncol 25:1183-9. 2007....
Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part IScott C Howard
International Outreach Program and Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Pediatr Blood Cancer 48:364-9. 2007..cure4kids.org. Identifying preventable causes of abandonment of therapy and documenting the nutritional status of patients treated at MISPHO centers are areas of active research...
Lack of benefit of early detection of relapse after completion of therapy for acute lymphoblastic leukemiaJeffrey E Rubnitz
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Pediatr Blood Cancer 44:138-41. 2005..We therefore sought to determine if detection of relapse by blood counts before the onset of symptoms provided any clinical benefit...
Vincristine-induced vocal cord paralysis in an infantDoralina L Anghelescu
Division of Anesthesia, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Paediatr Anaesth 12:168-70. 2002..Therefore, it should be suspected when stridor is present, and clinicians should consider visualization of the airway to establish the cause of upper airway compromise in infants receiving vincristine...
Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantationHiroto Inaba
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 116:2020-30. 2010..The number of long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is increasing; however, few studies have addressed their long-term pulmonary function...
Proxy assessment of quality of life in pediatric clinical trials: application of the Health Utilities Index 3Cheryl L Cox
Department of Nursing Research, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Qual Life Res 14:1045-56. 2005..With increased cure rates, pediatric oncology protocols increasingly seek to document the impact of treatment on patients' disease, symptoms, and functional capacity...
Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemiaSusana C Raimondi
Department of Pathology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Cancer 98:2715-22. 2003..In addition, the authors determined whether subdivision of the hypodiploid category served a prognostic purpose for these patients...
